Skip to main content

Table 4 Postoperative clinicopathological data of all patients enrolled

From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study

Clinicopathologic data PCG(N = 68)
M (IQR) orN (%)
CG (N = 41)
M (IQR) orN (%)
P
Pathological TNM staging    0.394
 I 18 8  
 II 18 10  
 III 29 23  
 IV 3 0  
Complications    0.081
 Yes 6 0  
 No 62 41  
Postoperative fever    0.379
 Yes 29 14  
 No 39 27  
Highest temperature (°C)    0.587
 < 37.3 39 27  
 37.3–38.5 22 12  
 > 38.5 7 2  
Screening examination    0.012*
 None 16 2  
 BRE + CRP 8 4  
 BRE + CRP + CT 4 5  
 Nucleic acid test 0 2  
Reason of fever    0.423
 Abdominal infection 1 0  
 Pulmonary infection 1 0  
 Incision infection 4 0  
 Anastomotic leakage 1 0  
 Unclear 17 11  
 None 5 3  
Transfusion of blood    0.422
 Yes 3 4  
 No 65 37  
Postoperative hospital stay (day) 7 (6–8) 9 (7–11) 0.000*
Total hospital stay (day) 11 (9–13) 15 (13–19) 0.000*
  1. PCG Pre-COVID-19 group, CG COVID-19 group, BRE Blood routine examination, CRP C-reactive protein, CT Computed tomography, Postoperative fever (≥37.3 °C)
  2. M Median, IQR Inter-quartile range, N Number
  3. * P < 0.05, statistically different